Asia: Threat or Opportunity? : Market Research Report

Asia: Threat or Opportunity?

Published: May. 5, 2008 - 40 Pages

Executive Summar: Strategic Considerations; Stakeholder Implications
The Importance of “The Asian Question: Global Economies; Considerations for the Pharmaceutical Industr
Factors Affecting Asian Pharmaceutical Markets: Outsourcing on the Rise; Emerging Markets; Intellectual Property Protection: Less Than Perfect, But Improving
China’s Pharmaceutical Market: Market Characteristic; Growth Area: API Manufacture; Growth Area: R&D Outsourcing
India’s Pharmaceutical Market: Market Characteristic; Intellectual Property Issues; Growth Area: API Manufacture; Growth Area: Outsourcing and R&D in India; Recent Dealmaking Activity
Japan’s Pharmaceutical Market: Market Characteristic; Growth Areas
Other Asian Pharmaceutical Markets: South Korea’s Pharmaceutical Market; Thailand’s Pharmaceutical Market; Singapore’s Pharmaceutical Market; Other Pharmaceutical Markets
Outlook: Short-Term Asian Implications; Long-Term Asian Implications; Looking at the Forest Instead of the Trees
Tables: 1. Annual Percentage Change in World Economic Output, 2005-2008; 2. Asian Countries to Dominate Global Economies in 2017; 3. Comparisons of Eight Pharmaceutical Markets, September 2007; 4. Exhibitor Growth at CPhI China, 2001-2007; 5. Select Western R&D Investments in China, 2004-2007; 6. Growth of the Domestic Pharmaceutical Market in India, 2005-2007; 7. Select Indian Company Financials; 8. Therapeutic Areas in India’s R&D Drug Pipeline; 9. Select Dealmaking Activity Between Indian Companies and Western Companies; 10. Retail Pharmacy Drug Sales in 13 Countries As Reported by IMS Healt; 11. Select Japanese Pharmaceutical Company Financials; 12. Mergers and Acquisitions by Japanese Companies, 2007-2008; 13. Generics Market Share in Different Countries by Volume and Value; 14. Select Asian Pharmaceutical Markets Ranked by Forecasted Growth, 2006-2011; 15. Select South Korean Pharmaceutical Companies Ranked by 2006 Sales
Figures: 1. Mature and Emerging Pharmaceutical Markets, 2008; 2. Characteristics of Rapidly Developing Asian Pharmaceutical Markets; 3. China and India: Pharmaceutical Market Comparison; 4. Size of the Chinese Pharmaceutical Market, 2001-2012; 5. Per Capita Healthcare Expenditure, Urban vs. Rural China, 1995-2004; 6. Number of Chinese Pharmaceutical Companies, 1985-2006; 7. Drug Master Files Submitted to the FDA by Indian Companies, 1996-2006; 8. Select Indian Pharmaceutical Companies’ Expenditures/Net Sales Ratio: 2001-2006; 9. The Pharmaceutical Industry, 2008: Is Asia an Opportunity or a Threat?

Abstract

Asian economic might is growing, and the Asian pharmaceutical markets and industry are growing along with it. Western pharmaceutical companies have become very interested in entering Asian markets and taking advantage of the opportunities they offer. Cost cutting alone, however, should not be the sole reason for multinational companies (MNCs) to outsource activities to Southeast Asia. Companies must make the effort to understand the local culture and business environment in each country they want to enter if they are to avoid unrealistic expectations and disappointments. The negative long-term effects could overshadow the benefits of short-term gains. Although Asian markets may prove challenging, they also offer significant opportunities for companies that focus their needs and then execute well-conceived strategies in specific countries.

Get the Answers You Need to Shape Your Strategy

PricewaterhouseCoopers forecasts that by 2020, the pharmaceutical markets of E7 countries will expand to capture 14% of an $800 billion global market. What are the most important factors and recent activities that are affecting the rise and fall of pharmaceutical importance in Asia? What opportunities does this growth present for Western pharmaceutical companies, and how might this significant growth pose a threat to the same companies?
There is no “one-size-fits-all” approach to doing business in an Asian country. Each company must address its own needs and goals and develop its own strategies. What are the most important short- and longterm implications for branded and generics pharmaceutical companies that want to operate in Asian markets?
The quality of Chinese-manufactured drugs and the thoroughness of FDA inspections was brought sharply into focus in early 2008 when as many as 81 deaths and hundreds of allergic reactions occurred in people taking Baxter Healthcare’s heparin. What are some of the drawbacks of doing business in Southeast Asia, and what is being done to improve the situation?
Local Asian companies are moving up the value chain of pharmaceutical drug development. What opportunities are available to them and what types of business alliances are they forming? In the long term, what does the future hold for these companies?

Scope

Surging growth in Asian economies: a look at the expanding pharmaceutical markets of Asia and the implications that this growth has for global pharmaceutical players.
Asian pharmaceutical market dynamics: outsourcing activities, emerging markets, and intellectual property landscapes.
China: market characteristics, growth in API manufacture, and R&D outsourcing activities.
India: market characteristics, intellectual property issues, growth in API manufacture, R&D outsourcing activities, and recent dealmaking activities.
Japan: market characteristics and recent areas of growth.
Coverage of other growing Asian pharmaceutical markets: South Korea, Thailand, Singapore, and others.
Outlook: short- and long-term implications of Asian markets on global pharmaceutical industries.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Asia: Threat or Opportunity?

Table of Contents

Abstract